Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

NCT01181427 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

137

Enrollment

INDUSTRY

Sponsor class

Conditions

HCV Infection

Interventions

DRUG: ABT-267
DRUG: Placebo
PROCEDURE: Blood Sample Collection
DRUG: Cytochrome P450 inhibitor

Sponsor

Abbott